Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47723
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ulutaş, Firdevs | - |
dc.contributor.author | Bozdemir, Aslı | - |
dc.contributor.author | Çelikyürek, Nevzat Atalay | - |
dc.contributor.author | Albayrak Yaşar, Canan | - |
dc.contributor.author | Çobankara, Veli | - |
dc.date.accessioned | 2023-01-09T21:29:46Z | - |
dc.date.available | 2023-01-09T21:29:46Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 2459-3516 | - |
dc.identifier.uri | https://doi.org/10.31138/mjr.32.3.243 | - |
dc.identifier.uri | https://hdl.handle.net/11499/47723 | - |
dc.description.abstract | Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ?7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease. © 2021 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Greek Rheumatology Society and Professional Association of Rheumatologists | en_US |
dc.relation.ispartof | Mediterranean Journal of Rheumatology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | co-morbid disease | en_US |
dc.subject | cut-off | en_US |
dc.subject | gout | en_US |
dc.subject | hyperuricemia | en_US |
dc.subject | allopurinol | en_US |
dc.subject | febuxostat | en_US |
dc.subject | uric acid | en_US |
dc.subject | adult | en_US |
dc.subject | age | en_US |
dc.subject | Article | en_US |
dc.subject | cardiovascular disease | en_US |
dc.subject | chronic kidney failure | en_US |
dc.subject | cohort analysis | en_US |
dc.subject | comorbidity | en_US |
dc.subject | controlled study | en_US |
dc.subject | cross-sectional study | en_US |
dc.subject | diabetes mellitus | en_US |
dc.subject | disease association | en_US |
dc.subject | drug use | en_US |
dc.subject | female | en_US |
dc.subject | follow up | en_US |
dc.subject | gender | en_US |
dc.subject | gout | en_US |
dc.subject | human | en_US |
dc.subject | hyperlipidemia | en_US |
dc.subject | hypertension | en_US |
dc.subject | hyperuricemia | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | middle aged | en_US |
dc.subject | nephrolithiasis | en_US |
dc.subject | observational study | en_US |
dc.subject | prediction | en_US |
dc.subject | receiver operating characteristic | en_US |
dc.subject | risk factor | en_US |
dc.subject | sensitivity and specificity | en_US |
dc.subject | Turk (people) | en_US |
dc.subject | Turkey (republic) | en_US |
dc.subject | uric acid blood level | en_US |
dc.title | Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 32 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 243 | en_US |
dc.identifier.endpage | 248 | en_US |
dc.identifier.doi | 10.31138/mjr.32.3.243 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57218161035 | - |
dc.authorscopusid | 57245894000 | - |
dc.authorscopusid | 57356247100 | - |
dc.authorscopusid | 57225265634 | - |
dc.authorscopusid | 24480613300 | - |
dc.identifier.scopus | 2-s2.0-85120064598 | en_US |
dc.identifier.scopusquality | Q4 | - |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu |
Files in This Item:
File | Size | Format | |
---|---|---|---|
CutOff-Value-of-Serum-Uric-Acid-for-Development-of-Gout-Disease-in-Patients-with-Multiple-CoMorbiditiesMediterranean-Journal-of-Rheumatology.pdf | 947.47 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
3
checked on Nov 16, 2024
Page view(s)
50
checked on Aug 24, 2024
Download(s)
24
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.